Global News

Bayer to restructure

Wednesday, May 27, 2015 12:23 PM

The Bayer Group has released a financial update for 2014. The company had strengthened its life science businesses HealthCare and CropScience through acquisitions and decided to demerge the MaterialScience business. Dr. Marijn Dekkers, management board chairman, also listed four strategic priorities for Bayer’s successful further development.

More... »

Quest Diagnostics

AVEO Oncology relocates corporate headquarters in Massachusetts

Wednesday, May 27, 2015 12:22 PM

AVEO Oncology, a biopharmaceutical company developing targeted therapies through biomarker-driven insights, has relocated its corporate headquarters to Cambridge, Mass.

More... »


Parexel enhances ClinPhone RTSM service

Wednesday, May 27, 2015 12:21 PM

Global CRO Parexel International has launched enhancements to its Randomization and Trial Supply Management (RTSM) service, ClinPhone RTSM. Parexel designed the enhanced service to simplify patient randomization and clinical supply management and to offer greater speed and flexibility in tailoring the service to meet the needs of clinical trials, while reducing delivery timelines. For the improvements, Parexel integrated the interactive response technology acquired from ClinIntel in October 2014 with Parexel’s experience in delivering RTSM services to thousands of studies to create an enhanced fourth-generation technology platform.

More... »

Mylan clarifies Perrigo offer

Wednesday, May 27, 2015 12:18 PM

Mylan was asked by the Irish Takeover Panel to issue the following clarification and retraction in accordance with the Irish Takeover Rules, relating to its firm intention to make an offer to acquire Perrigo. The clarification and retraction relates to certain forward-looking statements made by Mylan specifically during the pendency of the offer period concerning its long-stated target since 2012 of at least $6 in adjusted diluted earnings per share (EPS) by 2018, including recently in Mylan's first quarter earnings press release of May 5.

More... »

AbbVie completes acquisition of Pharmacyclics

Wednesday, May 27, 2015 12:17 PM

AbbVie has completed the acquisition of Pharmacyclics, enhancing AbbVie's scientific and commercial presence in oncology. Pharmacyclics primarily is aligned with the $24 billion global hematological oncology market with Imbruvica (ibrutinib), a BTK-inhibitor used to treat hematological cancers.

More... »

PatientsLikeMe appoints Jason Johnson executive vice president, head of R&D

Wednesday, May 27, 2015 12:15 PM

PatientsLikeMe has appointed Jason Johnson, Ph.D., executive vice president and head of R&D. Johnson leads the company's research, data science and informatics teams, which focus on analyzing and merging patient-reported and other data types to develop models of disease progression and generate new insights about disease, treatments and health. Johnson reports directly to CEO Martin Coulter.

More... »

The Global Drug-Lag Problem

Tuesday, May 26, 2015 08:00 AM

For all the advancements in medical research, certain regions of the world still wait to benefit from timely access to new drugs.

More... »

Baylor Research Institute, TGen Research Institute partner on precision medicine

Friday, May 22, 2015 01:57 PM

Baylor Research Institute (BRI) at Dallas, Texas and the Translational Genomics Research Institute (TGen) in Phoenix, Ariz., have inked an agreement that will focus on accelerating early detection and treatments for patients with a broad range of cancers.

More... »

Fosun Pharma, HOPU Investments, CEL Healthcare Fund, WuXi PharmaTech to acquire Ambrx

Friday, May 22, 2015 01:50 PM

A consortium—consisting of entities affiliated with Shanghai Fosun Pharmaceutical Group, HOPU InvestmentsChina Everbright’s Healthcare Fund and WuXi PharmaTech—has signed a merger agreement to acquire Ambrx. The transaction is expected to close in the second quarter of 2015, subject to receipt of certain regulatory approvals and satisfaction of customary closing conditions.

More... »

Foundation for Prader-Willi Research receives $1M for clinical initiatives

Friday, May 22, 2015 01:49 PM

The Foundation for Prader-Willi Research (FPWR), a nonprofit organization dedicated to supporting research to advance the understanding and treatment of Prader-Willi syndrome (PWS), has received the organization's largest donation to date. Philanthropists Leon and Irina Shaulov contributed $1 million in support of the organization's research programs and clinical initiatives.

More... »

`

CWWeekly

May 26

inVentiv Health aims to help sponsors prepare for new E.U. regulations on observational studies

ACRP partners with CRO Analytics to measure investigative sites' views of clinical trial quality

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs